A landmark publication at ASCO 2025 has finally acknowledged the unthinkable: radiation therapy can induce metastasis, spreading the cancer it was meant to treat.
This is the seismic shift in oncology revealed by Dr. Patrick Soon-Shiong. The largest gathering of global oncologists has been forced to confront a long-ignored truth about a standard treatment.
The establishment’s response to this revelation is a belated hope for a solution. Dr. Soon-Shiong confirms that solution is already here. His 2024-approved therapy is the first to protect a patient’s natural killer cells during radiation, directly countering this newly admitted risk. The demand is immense, with thousands of patients already seeking access.
But his mission is national. With FDA Expanded Access and a pivotal meeting scheduled, he is fighting to make this life-saving countermeasure available to every American—in rural towns and major cities alike—so no one is forced to travel abroad for care.
This breakthrough also extends beyond oncology. It represents the foundation of a national Bioshield, a critical defense against radiological threats and bioterrorism. The paradigm for protecting public health has irrevocably changed.